Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-09-12 | Mereo BioPharma Group plc | Scots-Knight Denise
(Chief Executive Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 88657 | $4.22 - $4.47 | $381,422 |
| 2024-09-12 | Mereo BioPharma Group plc | Lewicki John A.
(Chief Scientific Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 16149 | $4.22 - $4.47 | $69,476 |
| 2024-09-12 | Mereo BioPharma Group plc | Sermon Charles
(General Counsel) |
S | American Depositary Shares representing Ordinary Shares | D | 30926 | $4.22 - $4.47 | $133,050 |
| 2024-09-12 | Mereo BioPharma Group plc | Fox Christine Ann
(Chief Financial Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 28286 | $4.22 - $4.47 | $121,691 |
| 2024-09-12 | Mereo BioPharma Group plc | Hughes-Wilson Ale...
(See Remarks) |
S | American Depositary Shares representing Ordinary Shares | D | 148110 | $4.22 - $4.47 | $637,201 |
| 2024-09-11 | Mereo BioPharma Group plc | Sermon Charles
(General Counsel) |
M | American Depositary Shares representing Ordinary Shares | A | 65600 | $0.00 - $0.00 | $0 |
| 2024-09-11 | Mereo BioPharma Group plc | Fox Christine Ann
(Chief Financial Officer) |
M | American Depositary Shares representing Ordinary Shares | A | 60000 | $0.00 - $0.00 | $0 |
| 2024-09-11 | Mereo BioPharma Group plc | Lewicki John A.
(Chief Scientific Officer) |
M | American Depositary Shares representing Ordinary Shares | A | 46000 | $0.00 - $0.00 | $0 |
| 2024-09-11 | Mereo BioPharma Group plc | Scots-Knight Denise
(Chief Executive Officer) |
M | American Depositary Shares representing Ordinary Shares | A | 188060 | $0.00 - $0.00 | $0 |
| 2024-09-11 | Mereo BioPharma Group plc | Hughes-Wilson Ale...
(See Remarks) |
M | American Depositary Shares representing Ordinary Shares | A | 208333 | $0.00 - $1.40 | $206,416 |
| 2024-08-22 | Mereo BioPharma Group plc | PAKIANATHAN DEEPIKA
(Director) |
S | American Depositary Shares representing Ordinary Shares | D | 105244 | $4.43 - $4.43 | $466,209 |
| 2024-08-22 | Mereo BioPharma Group plc | PAKIANATHAN DEEPIKA
(Director) |
M | American Depositary Shares representing Ordinary Shares | A | 105244 | $0.94 - $3.87 | $151,113 |
| 2024-06-25 | Mereo BioPharma Group plc | Sermon Charles
(General Counsel) |
S | American Depositary Shares representing Ordinary Shares | D | 46389 | $3.39 - $3.69 | $161,676 |
| 2024-06-25 | Mereo BioPharma Group plc | Lewicki John A.
(Chief Scientific Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 24224 | $3.39 - $3.69 | $84,425 |
| 2024-06-25 | Mereo BioPharma Group plc | Fox Christine Ann
(Chief Financial Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 42429 | $3.39 - $3.69 | $147,875 |
| 2024-06-25 | Mereo BioPharma Group plc | Scots-Knight Denise
(Chief Executive Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 132985 | $3.39 - $3.69 | $463,486 |
| 2024-06-21 | Mereo BioPharma Group plc | Lewicki John A.
(Chief Scientific Officer) |
M | American Depositary Shares representing Ordinary Shares | A | 69000 | $0.00 - $0.00 | $0 |
| 2024-06-21 | Mereo BioPharma Group plc | Scots-Knight Denise
(Chief Executive Officer) |
M | American Depositary Shares representing Ordinary Shares | A | 282090 | $0.00 - $0.00 | $0 |
| 2024-06-21 | Mereo BioPharma Group plc | Sermon Charles
(General Counsel) |
M | American Depositary Shares representing Ordinary Shares | A | 98400 | $0.00 - $0.00 | $0 |
| 2024-06-21 | Mereo BioPharma Group plc | Fox Christine Ann
(Chief Financial Officer) |
M | American Depositary Shares representing Ordinary Shares | A | 90000 | $0.00 - $0.00 | $0 |
| 2024-06-21 | Mereo BioPharma Group plc | Hughes-Wilson Ale...
(See Remarks) |
M | American Depositary Shares representing Ordinary Shares | A | 60000 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |